Indiana Biosciences Research Institute

The Indiana Biosciences Research Institute (IBRI) is a leading translational medicine institute dedicated to advancing life sciences, with a focus on eliminating disease and enhancing human health. Located at 1210 Waterway Blvd, Ste. 2000, Indianapolis, Indiana 46202, US, the Indiana Biosciences Research Institute connects early-stage biotech firms with academic researchers, backed by the mission and resources of industry leaders, investors, and philanthropic partners, fostering an independent model to conquer disease.

With a strategic approach to accelerating drug discovery, the Indiana Biosciences Research Institute supports early-stage companies through investment, talent acquisition, and providing essential space. Research at IBRI spans the frontiers of diabetes, metabolic disease, Alzheimer’s disease, and rare pediatric diseases, fueled by entrepreneurial creativity and groundbreaking scientific work. The Indiana Biosciences Research Institute cultivates talent and efficiently bridges the gap between research-driven inquiry and profit-driven drug development, creating a clear pathway to clinical trials.

The Indiana Biosciences Research Institute’s novel financing model ensures that intellectual property is sold back to industry or spun off when discoveries are ready for clinical trials, creating a direct stream of revenue. By nurturing scientific bench work, advancing drug discovery, supporting continuous workforce development, and providing returns for investors and impact for donors, IBRI demonstrates a pioneering approach to bioscience research. We invite the manager of the Indiana Biosciences Research Institute to create a customized and exclusive company showcase and product listing on our platform to further highlight your contributions to the industry.